Stryker expands board to 12, elects Quest Diagnostics CEO Jim Davis effective Jan 1, 2027

STRYKER CORP

Board increased authorized directors from 11 to 12 and elected James E. Davis to fill the vacancy; term begins January 1, 2027.
Davis has been CEO and President of Quest Diagnostics since November 2022 and Chairman of the Quest board since April 2023.
Prior roles: CEO of InSightec, two decades at GE including five years leading GE's MRI business, and earlier McKinsey client work.
Not appointed to any board committee at this time; pay will match other non-employee directors per the 2026 proxy statement.
CEO Kevin Lobo cited Davis's healthcare experience and medical-technology understanding as the rationale for the nomination.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.